- Exchange: NASDAQ GS
- Sector: Health Care
- Industry: Biotech & Pharma
- Sub-Industry: Specialty Pharma
Progenics Pharmaceuticals Inc+ Add to Watchlist
PGNX:US4.7200 USD 0.1100 2.39%
As of 20:10:00 ET on 10/24/2014.
Company Profile for Progenics Pharmaceuticals Inc (PGNX)
Progenics Pharmaceuticals, Inc. is a biopharmaceutical company. The Company develops and distributes therapeutic products to treat the unmet medical needs of patients with debilitating conditions and life-threatening diseases. Progenics' principal programs are directed toward supportive care, virology (human immunodeficiency virus and hepatitis C virus infections), and oncology.
Progenics Pharmaceuticals Inc
Key Executives for Progenics Pharmaceuticals Inc (PGNX)
|Mark Robert BakerChief Executive Officer||Robert J IsraelExec VP:Medical Affairs|
|Hagop YoussoufianExec VP:Research & Development||Nitya G RaySenior VP:Manufacturing|
|Vivien WongSenior VP:Operations & Portfolio||Angelo W Lovallo JrVP:Finance/Treasurer|
|Ann Marie AssummaVP:Regulatory Affairs||Amy MartiniDirector:Corporate Affairs|
|David E MartinGeneral Counsel|